Skip to main content

Table 3 Ovulation induction and embryology laboratory outcomes

From: Association between gestational trophoblastic disease (GTD) history and clinical outcomes in in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles

Characteristics

Control group

(n = 132)

GTD group

(n = 44)

P value

Type of ART n (%)

  

< 0.001

 IVF

108 (81.8%)

15 (34.1%)

 

 ICSI

24 (18.2%)

23 (52.3%)

 

 PGT

0 (0.0%)

6 (13.6%)

 

Total gonadotrophin-releasing hormone agonist dose (IU) a

0.9 (0.0–3.8)

1.2 (0.0–3.8)

0.407

Days of gonadotropin b

10.0 (7.0–20.0)

10.0 (5.0–18.0)

0.602

Total gonadotropin dose (IU) a

2180.5 ± 714.5

1977.7 ± 897.5

0.135

Triger day

 FSH a

14.2 ± 5.2

12.5 ± 4.2

0.054

 E2 a

2907.5 ± 1667.5

3418.8 ± 2262.2

0.111

 LH a

2.0 ± 1.6

2.5 ± 2.6

0.123

 P a

0.7 ± 0.5

0.7 ± 0.4

0.851

 Follicle (14–16 mm) b

9.0 (1.0–20.0)

11.5 (1.0–24.0)

0.239

 Triger day endometrial thickness (mm) a

11.5 ± 2.4

9.3 ± 2.5

< 0.001

No. of mature oocytes b

9.0 (1.0–22.0)

10.0 (1.0–23.0)

0.929

Normal fertilization rate a

79%

80%

0.986

No. of degenerating cleavages a

0.1 ± 0.6

0.4 ± 0.7

0.005

No. of good-quality embryos a

4.6 ± 2.6

3.5 ± 3.2

0.019

No. of abandoned embryos a

2.8 ± 2.2

4.0 ± 4.2

0.018

  1. a Values are mean ± standard deviation.
  2. b Values are median and Min-Max.
  3. P value: For continuous variables, it can be obtained by Kruskal Wallis rank sum test. If the count variable has a theoretical number < 10, it can be obtained by Fisher’s exact probability test.